Related Experiment Videos
Accentuation of differentially expressed proteins using phage technology
R Lee Suber1, Vincent L Flanders, Michael J Campa
1Department of Radiology, Duke University Medical Center, Durham, NC, USA.
Analytical Biochemistry
|September 29, 2004
Summary
Researchers developed a new method using M13 bacteriophage to identify proteins specific to diseases like lung cancer. This approach enhances differential protein expression analysis in biological samples.
Area of Science:
- Biotechnology
- Proteomics
- Molecular Biology
Background:
- Protein profiling is crucial for identifying disease-specific proteins and understanding differential expression.
- Existing differential profiling techniques are improving, but novel complementary platforms are needed.
- Exploring alternative expression platforms can enhance the discovery of disease biomarkers.
Purpose of the Study:
- To develop and validate a novel protein profiling method using random peptide-expressing M13 bacteriophage.
- To accentuate differentially expressed proteins in biological specimens for disease elucidation.
- To demonstrate the method's utility in identifying lung cancer-specific proteins.
Main Methods:
- Utilized the amplification and selection capabilities of random peptide-expressing M13 bacteriophage.
- Applied the novel method to compare protein expression in lung cancer tissue versus normal lung tissue.
- Focused on accentuating differentially expressed proteins for enhanced detection.
Main Results:
- Successfully demonstrated the identification of differentially expressed proteins in lung cancer tissue.
- The M13 bacteriophage method effectively highlighted proteins distinct between diseased and normal tissues.
- Validated the potential of this novel approach for differential protein analysis.
Conclusions:
- The developed M13 bacteriophage-based method is a viable novel approach for protein profiling.
- This technique effectively accentuates differentially expressed proteins, aiding in disease biomarker discovery.
- The method is broadly applicable to various sample types beyond the lung cancer model.